Solid Q3 performance
Ossur delivered sales of USD 192.9m (1-2% below expectations) in Q3 for 9% reported growth and 7% organic growth. Sales was driven by a better than expected 12% organic growth in the largest Prosthetics segment, while the the smaller Bracing & Support segment fell short with 1% organic growth. Gross margin came in 30-120bp below expectations, while unchanged OPEX spend year-on-year saw EBITDA (pre-items) come in at $36.3m (1-8% better than expectations) for a margin 40-180bp better than expectations. Net Profit came to $13.9m (8-9% below expectations) on higher interest rates and adverse FX impact.
Aktuellt
SENASTE
